0
The intriguing finding that smokers did better than non-smokers in a clinical trial for an experimental cancer treatment led researchers to develop a drinkable, carbon monoxide-infused foam that boosted the effectiveness of the therapy, known as autophagy inhibition, in mice and human cells. The results suggest that therapeutic levels of carbon monoxide, delivered using gas-entrapping materials (GEMs), can increase the anti-cancer activity of autophagy inhibitors, which might have potential to improve therapies for many different cancers.